Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

About one billion people worldwide take regular aspirin, usually to prevent heart attacks or strokes. However, a study in The Lancet suggests a more tailored strategy is required. The team, led by Peter Rothwell of the Nuffield Department of Clinical Neurosciences studied detailed data from their own previous trials (with over 130,000 participants) and showed that standard low-dose aspirin (75-100mg daily) was indeed only effective in preventing heart attacks and strokes in people weighing less than 70kg.

Read More

Read the Original Paper